Javier Pérez Gisbert-rekin lankidetzan egindako argitalpenak (3)

2012

  1. The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat-ments

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1303-1312

2008

  1. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers

    Pharmacological Research, Vol. 58, Núm. 1, pp. 77-84

2006

  1. Clinical trial evaluating amoxicillin and clarithromycin hydrogels (chitosan-polyacrylic acid polyionic complex) for H. pylori eradication

    Journal of Clinical Gastroenterology, Vol. 40, Núm. 7, pp. 618-622